Kyprolis (carfilzomib) for Injection 

Detailed View: Safety Labeling Changes Approved By FDA Center for Drug Evaluation and Research (CDER) January 2016 WARNINGS AND PRECAUTIONS Cardiac Toxicities …These patients may be at greater risk for cardiac complications and...
Source: Drugs.com - Labeling Changes - Category: Drugs & Pharmacology Source Type: alerts